Pulished Date August, 2019
ID: 165
Share on
Share on

North America Biomarkers Market By Product (Consumables, Services, & Software), Type (Safety Biomarkers, Efficacy Biomarkers), Application (Diagnostics, Drug Discovery), And Disease Indications (Cancer, Cardiovascular) - Market Analysis, Size, Geographic Countries Analysis, Competitive Strategies Analysis And Forecasts (2018 To 2023)

Pulished: August, 2019
ID: 165
Pages: 135

Biomarkers are described as the biological molecules or genes assist in crucial clinical decisions and diagnosis of health conditions in patients. These are also known as molecular markers or signature molecules and used to analyze the pharmacologic responses, biological & pathological conditions. Biomarkers are found extensively in body fluids and tissues. Biomarkers are helpful in drug discovery & development processes and assessment of disease conditions.

North America biomarkers market is expected to reach USD 24.4 billion by 2023 from USD 13.97 billion in 2018 growing at a CAGR of 11.80% during forecast period 2018-2023

Growing number of cancer patients, rising adoption of advanced technologies (such as advanced high throughput technologies), increasing research to discover & develop the innovative biomarkers, and existence of huge number of pharmaceutical companies are driving the growth of biomarkers market in North America. In addition, growing funding from public & private organizations, presence of major market players, and increasing collaborations among the pharmaceutical companies are further propelling the growth of biomarkers market in North America. However, poor regulatory systems and reimbursement policies for the validation of biomarkers tests are restraining the growth of biomarkers market in North America.

North America biomarkers market is segmented based on the product, type, application, and disease indications. Based on product, the market is further sub-segmented as consumables, software, and services. Based on type, the market is segmented as safety biomarkers, efficacy biomarkers, and validation biomarkers. Biomarkers application is further segmented as diagnostics developments, drug discovery & developments, personalized medicine, and disease risk assessment. Based on disease indications, the market is segmented as cancer, cardiovascular, neurological, and immunological disorders.

On the basis of geographical areas, North America biomarkers market is segmented as U.S., and Canada.

The key players in biomarkers market include, Bio-Rad Laboratories (U.S.), Qiagen N.V. (Netherlands), Enzo Biochem (U.S.), PerkinElmer, Inc. (U.S.), Merck & Co, Inc. (U.S.), EKF Diagnostics Holdings plc. (U.S.), Meso Scale Diagnostics, LLC (U.S.), Singulex, Inc. (U.S.), BioSims Technologies (France), Cisbio Bioassays (France), and Signosis, Inc. (U.S.).

  1. Introduction

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                          

                1.4 General Study Assumptions                                                                

  1. Research Methodology

                2.1 Introduction                                                                               

                2.2 Research Phases                                                                      

                                2.2.1 Secondary Research                                                           

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                      

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design                                                                         

                2.4 Study Timeline                                                                          

  1. Overview

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 New Developments                                                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                                              

  1. Market Segmentation

                5.1          Product                                                               

                                5.1.1 Introduction                                                           

                                5.1.2 Consumables                                                         

                                5.1.3 Software                                                  

                                5.1.4 Services     Growth Hormone Therapy                                         

                5.2          Type                                                     

                                5.2.1 Introduction                                                           

                                5.2.2 Safety Biomarkers                                                               

                                5.2.3 Efficacy Biomarkers                                                             

                                5.2.4 Validation Biomarkers                                                        

                5.3          Application                                                        

                                5.3.1 Introduction                                                           

                                5.3.2 Diagnostics Development                                                 

                                5.3.3 Drug Discovery and Development                                                

                                5.3.4 Personalised Medicine                                                      

                                5.3.5 Disease Risk Assessment                                                  

                                5.3.6 Other Applications                                                               

                5.4          Disease Indications                                                        

                                5.4.1 Introduction                                                           

                                5.4.2 Cancer                                                      

                                5.4.3 CardiovascularDisorders                                                    

                                5.4.4 Neurological Disorders                                                       

                                5.4.5 Immunological Disorders                                                  

                                5.4.6 Other Diseases                                                      

  1. Geographical Analysis

                                6.1 Introduction                                                               

                                6.2 United States                                                            

                                6.3 Canada                                                         

  1. Strategic Analysis

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

  1. Market Leaders' Analysis

                8.1 Bio-Rad Laboratories (U.S.)                                                 

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Strategic Evaluation and Operations                                                            

                                8.1.4 Financial analysis                                                  

                                8.1.5 Legal issues                                                             

                                8.1.6 Recent Developments                                                       

                                8.1.7 SWOT analysis                                                       

                                8.1.8 Analyst View                                                          

                8.2 Qiagen N.V. (Netherlands)                                                  

                8.3 Enzo Biochem (U.S.)                                                               

                8.4 PerkinElmer, Inc. (U.S.)                                                         

                8.5 Merck & Co, Inc. (U.S.)                                                          

                8.6 EKF Diagnostics Holdings plc. (U.S.)                                                  

                8.7 Meso Scale Diagnostics, LLC (U.S.)                                                    

                8.8 Singulex, Inc. (U.S.)                                                 

                8.9 BioSims Technologies (France)                                                           

                8.10 Cisbio Bioassays (France)                                                   

                8.11 Signosis, Inc. (U.S.)                                                               

  1. Competitive Landscape

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                                         

                9.4 New Product Launches                                                                         

  1. Expert Opinions

                10.1 Market Outlook                                                                     

                10.2 Investment Opportunities                                                                 


  1. List of Tables
  2. List of Figures
  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Biomarkers Market By Region, From 2018-2023 ( USD Billion )
  2. North America Biomarkers Market By Product, From 2018-2023 ( USD Billion )
  3. North America Consumables Market By Region, From 2018-2023 ( USD Billion )
  4. North America Software Market By Region, From 2018-2023 ( USD Billion )
  5. North America Services Market By Region, From 2018-2023 ( USD Billion )
  6. North America Biomarkers Market By Type, From 2018-2023 ( USD Billion )
  7. North America Safety Biomarkers Market By Region, From 2018-2023 ( USD Billion )
  8. North America Efficacy Biomarkers Market By Region, From 2018-2023 ( USD Billion )
  9. North America Validation Biomarkers Market By Region, From 2018-2023 ( USD Billion )
  10. North America Biomarkers Market By Application, From 2018-2023 ( USD Billion )
  11. North America Diagnostics Development Market By Region, From 2018-2023 ( USD Billion )
  12. North America Drug Discovery and Development Market By Region, From 2018-2023 ( USD Billion )
  13. North America Personalised Medicine Market By Region, From 2018-2023 ( USD Billion )
  14. North America Disease Risk Assessment Market By Region, From 2018-2023 ( USD Billion )
  15. North America Other Applications Market By Region, From 2018-2023 ( USD Billion )
  16. North America Biomarkers Market By Disease Indications, From 2018-2023 ( USD Billion )
  17. North America Cancer Market By Region, From 2018-2023 ( USD Billion )
  18. North America Cardiovascular Disorders Market By Region, From 2018-2023 ( USD Billion )
  19. North America Neurological Disorders Market By Region, From 2018-2023 ( USD Billion )
  20. North America Immunological Disorders Market By Region, From 2018-2023 ( USD Billion )
  21. North America Other Diseases Market By Region, From 2018-2023 ( USD Billion )
  22. United States Biomarkers Market By Product, From 2018-2023 ( USD Billion )
  23. United States Biomarkers Market By Type, From 2018-2023 ( USD Billion )
  24. United States Biomarkers Market By Application, From 2018-2023 ( USD Billion )
  25. United States Biomarkers Market By Disease Indications, From 2018-2023 ( USD Billion )
  26. Canada Biomarkers Market By Product, From 2018-2023 ( USD Billion )
  27. Canada Biomarkers Market By Type, From 2018-2023 ( USD Billion )
  28. Canada Biomarkers Market By Application, From 2018-2023 ( USD Billion )
  29. Canada Biomarkers Market By Disease Indications, From 2018-2023 ( USD Billion )

Please wait. . . . Your request is being processed


$ 1234 3335

Click for Request Sample